In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Do Dx-Life Science Synergies Exist? Beckman Says 'You Bet They Do'

Executive Summary

Life sciences and clinical diagnostics seem to have a lot in common, but their customer needs, margins and product life cycles differ significantly. Beckman Coulter, one of the few large diagnostics companies with significant life science commitments, argues vociferously in favor of the strategic value of leveraging both businesses, despite many difficulties. Its MHC tetramer program is a prime example of its strategy.

Related Content


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts